Xtx Topco LTD Annexon, Inc. Transaction History

Xtx Topco LTD

$1.13 Billion
Q4 2024

A detailed history of Xtx Topco LTD transactions in Annexon, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 35,151 shares of ANNX stock, worth $99,477. This represents 0.02% of its overall portfolio holdings.

Number of Shares

35,151

Holding current value

$99,477

% of portfolio

0.02%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$4.44 - $7.63 $156,070 - $268,202	35,151 New	35,151 $180,000
Q2 2022 Aug 15, 2022	SELL	$2.11 - $4.06 $77,525 - $149,172	-36,742 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.73 - $11.94 $100,305 - $438,699	36,742 New	36,742 $100,000

Others Institutions Holding ANNX

# of Institutions

156

Shares Held

98.2M

Call Options Held

146K

Put Options Held

174K

Satter Management Co., L.P.

7.41M
Shares

$21 Million
71.99% of portfolio
Bvf Inc San Francisco, CA

7M
Shares

$19.8 Million
1.34% of portfolio
Black Rock Inc. New York, NY

6.59M
Shares

$18.6 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

6.3M
Shares

$17.8 Million
2.53% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

5.63M
Shares

$15.9 Million
0.07% of portfolio

View Full List

About Annexon, Inc.

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $135M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

More about ANNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.

Account